🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#UCSF doctors team with the SF Opera to ensure a healthy visit to "The Barber..." soundcloud.com/user-176501713…

UCSF announces the creation of the Kunal Patel UCSF Innovation Fund in support of our Catalyst Program for advancing UCSF discoveries with clinical impact and commercial potential. innovation.ucsf.edu/Patel-UCSF-Inn…

The UCSF Health Awards returns for the 3rd Annual Award show to recognize the achievements of innovative health tech companies that are dramatically improving healthcare through the use of technology. ucsfhealthhub.com/2021-ucsf-heal…

Congratulations to UCSF Neurosurgeon dr. Edward Chang on his work translating thoughts into language. sfchronicle.com/health/article…

Sonoma Biotherapeutics Raises $265M. "We are taking cells out of the body of patients, and we’re manipulating them and putting them back into the patients,” said CEO and president Jeff Bluestone, “The cells become the medicine.” geekwire.com/2021/sonoma-bi…

Encellin, a regenerative medicine biotech company founded at the University of California San Francisco (UCSF), and developing novel cell-based approaches to deliver sustained therapies with a single implant, today announced the closing of a $5.9M Seed financing round.

UCSF Founded eFFECTOR Debuts as a Publicly Traded Next-Generation Oncology Company. Congratulations to UCSF co-founders Kevan Shokat and Davide Ruggero. globenewswire.com/news-release/2…

Born in California presented by @USbank features University of California’s most investment-worthy startups seeking Seed & Series A investors. Learn more about sponsorship/investment opportunities & attending this invite-only event at @UCICove11/17-11/18: bit.ly/uc-born-2021 #USbank

Awesome work happening with UCSF CDHI and the UCSF Lung Transplant Program! In this issue of the Digital Byte, Steve Hays describes the new virtual care program for patients to monitor their lung function at home. #virtualcare #digitalhealth youtu.be/dZxyiXYJ_As

UCSF Innovation Ventures wishes neuroscientist Adam Gazzaley, a big congratulations as his digital medicine startup, Akili Interactive, goes public! lnkd.in/gQFseQwC

NephroSant Launches Two-Year Study of 2,000 Kidney Transplant Recipients. prnewswire.com/news-releases/…

We cheer on UCSF research scientist Adam Abate, as Mission Bio, the newco founded on Dr. Abate's technology, launches a first-in-class single-cell genomics, solid tumor solution on their Tapestri Platform. prnewswire.com/news-releases/…

UCSF Innovation Ventures supports racial equality in medicine and the law. Congratulations to the Honorable Justice Ketanji Brown Jackson. whitehouse.gov/kbj/

A video game developed by UCSF Professor of Neurology Adam Gazzaley's start-up – Akili Interactive – improves cognitive symptoms. fiercebiotech.com/medtech/akilis…

Born in California®, Presented by U.S. Bank returns to UCI Nov. 16-17. This invitation-only event brings together top startups from all 10 University of California campuses for a two-day pitch and demo event. Interested investors or sponsors should visit: bit.ly/3fTay4Q

UCSF Speakers Reach Record Numbers at Precision Medicine World Conference- highlights, panel videos! #PMWC23 precisionmedicine.ucsf.edu/news/ucsf-spea… Precision Medicine World Conference Keith Yamamoto Atul Butte ARPA-H Marina Sirota @DrLauraEsserman Aleksandar Rajkovic Vivek Rudrapatna Rohit Vashisht UCSF School of Pharmacy Lea T. Grinberg, M.D, Ph.D Dani Ushizima Ph.D.

Based on initial positive data, Exai is proud to announce expanded participation in the I-SPY 2 Trial to advance our novel RNA-based liquid biopsy platform for breast cancer. businesswire.com/news/home/2023…’s-Novel-RNA-based-Liquid-Biopsy-Platform-in-Breast-Cancer

ENDC Anniversary Guest Speakers Announced! sfendc.com/so/10OSue8ts?l…